224 related articles for article (PubMed ID: 28004432)
1. Role of coagulation factors in urological malignancy: A prospective, controlled study on prostate, renal and bladder cancer.
Alevizopoulos A; Tyritzis S; Leotsakos I; Anastasopoulou I; Pournaras C; Kotsis P; Katsarou O; Alamanis C; Stravodimos K; Constantinides C
Int J Urol; 2017 Feb; 24(2):130-136. PubMed ID: 28004432
[TBL] [Abstract][Full Text] [Related]
2. Serotonin used as prognostic marker of urological tumors.
Jungwirth N; Haeberle L; Schrott KM; Wullich B; Krause FS
World J Urol; 2008 Oct; 26(5):499-504. PubMed ID: 18581119
[TBL] [Abstract][Full Text] [Related]
3. Circulating mitochondrial DNA in serum: a universal diagnostic biomarker for patients with urological malignancies.
Ellinger J; Müller DC; Müller SC; Hauser S; Heukamp LC; von Ruecker A; Bastian PJ; Walgenbach-Brunagel G
Urol Oncol; 2012; 30(4):509-15. PubMed ID: 20870429
[TBL] [Abstract][Full Text] [Related]
4. Serum level of immunosuppressive acidic protein in patients with urological malignancies.
Pu YS; Tsai TC; Chiu TY; Hsieh TS; Chen J; Chen SC; Lin MC; Hsu TC
J Formos Med Assoc; 1991 May; 90(5):498-503. PubMed ID: 1680990
[TBL] [Abstract][Full Text] [Related]
5. Plasma tissue factor antigen in localized prostate cancer: distribution, clinical significance and correlation with haemostatic activation markers.
Langer F; Chun FK; Amirkhosravi A; Friedrich M; Leuenroth S; Eifrig B; Bokemeyer C; Francis JL
Thromb Haemost; 2007 Mar; 97(3):464-70. PubMed ID: 17334515
[TBL] [Abstract][Full Text] [Related]
6. [Analysis of the factors associated with abnormal coagulation and prognosis
in patients with non-small cell lung cancer].
Li Y; Wei S; Wang J; Hong L; Cui L; Wang C
Zhongguo Fei Ai Za Zhi; 2014 Nov; 17(11):789-96. PubMed ID: 25404269
[TBL] [Abstract][Full Text] [Related]
7. Role of C-reactive protein in urological cancers: a useful biomarker for predicting outcomes.
Saito K; Kihara K
Int J Urol; 2013 Feb; 20(2):161-71. PubMed ID: 22897628
[TBL] [Abstract][Full Text] [Related]
8. Advanced prostate cancer activates coagulation: a controlled study of activation markers of coagulation in ambulatory patients with localized and advanced prostate cancer.
Kohli M; Fink LM; Spencer HJ; Zent CS
Blood Coagul Fibrinolysis; 2002 Jan; 13(1):1-5. PubMed ID: 11994561
[TBL] [Abstract][Full Text] [Related]
9. Clinical and Prognostic Significance of Coagulation Assays in Pancreatic Cancer Patients With Absence of Venous Thromboembolism.
Sun W; Ren H; Gao CT; Ma WD; Luo L; Liu Y; Jin P; Hao JH
Am J Clin Oncol; 2015 Dec; 38(6):550-6. PubMed ID: 24401666
[TBL] [Abstract][Full Text] [Related]
10. Serum Vitamin D is Not Helpful for Predicting Prostate Cancer Aggressiveness Compared with the Prostate Health Index.
Stephan C; Lein M; Matalon J; Kilic E; Zhao Z; Busch J; Jung K
J Urol; 2016 Sep; 196(3):709-14. PubMed ID: 26976204
[TBL] [Abstract][Full Text] [Related]
11. Correlation between coagulation function, tumor stage and metastasis in patients with renal cell carcinoma: a retrospective study.
Xiao B; Ma LL; Zhang SD; Xiao CL; Lu J; Hong K; Liao HY
Chin Med J (Engl); 2011 Apr; 124(8):1205-8. PubMed ID: 21542997
[TBL] [Abstract][Full Text] [Related]
12. [Utility of the serum CRP value for assessing the prognosis and therapeutic response of urological malignancies].
Köhler A; Eggers H; Kuczyk MA; Schrader AJ; Steffens S
Aktuelle Urol; 2013 Nov; 44(6):452-5. PubMed ID: 24258396
[TBL] [Abstract][Full Text] [Related]
13. Systemic Coagulation Markers Especially Fibrinogen Are Closely Associated with the Aggressiveness of Prostate Cancer in Patients Who Underwent Transrectal Ultrasound-Guided Prostate Biopsy.
Wang FM; Xing NZ
Dis Markers; 2021; 2021():8899994. PubMed ID: 33532007
[TBL] [Abstract][Full Text] [Related]
14. [Serum concentration of type IV collagen in urological cancer--comparison with serum concentration of laminin].
Isobe H; Iwata S; Fujime M; Kitagawa R
Nihon Hinyokika Gakkai Zasshi; 1993 Mar; 84(3):457-62. PubMed ID: 8515631
[TBL] [Abstract][Full Text] [Related]
15. Urinary tissue factor levels in patients with bladder and prostate cancer.
Lwaleed BA; Francis JL; Chisholm M
Eur J Surg Oncol; 2000 Feb; 26(1):44-9. PubMed ID: 10718179
[TBL] [Abstract][Full Text] [Related]
16. Differences in Urinary Amino Acid Patterns in Individuals with Different Types of Urological Tumor Urinary Amino Acid Patterns as Markers of Urological Tumors.
Duskova K; Vesely S; DO Carmo Silva J; Cernei N; Zitka O; Heger Z; Adam V; Havlova K; Babjuk M
In Vivo; 2018; 32(2):425-429. PubMed ID: 29475932
[TBL] [Abstract][Full Text] [Related]
17. Monocyte tissue factor levels in cancer patients.
Lwaleed BA; Francis JL; Chisholm M
Saudi Med J; 2000 Aug; 21(8):722-9. PubMed ID: 11423883
[TBL] [Abstract][Full Text] [Related]
18. Plasma thymosin-α1 level as a potential biomarker in urothelial and renal cell carcinoma.
Jou YC; Tsai YS; Hsieh HY; Chen SY; Tsai HT; Chen KJ; Wang ST; Shiau AL; Wu CL; Tzai TS
Urol Oncol; 2013 Nov; 31(8):1806-11. PubMed ID: 22609059
[TBL] [Abstract][Full Text] [Related]
19. Circulating tumour cells as biomarkers of prostate, bladder, and kidney cancer.
Gorin MA; Verdone JE; van der Toom E; Bivalacqua TJ; Allaf ME; Pienta KJ
Nat Rev Urol; 2017 Feb; 14(2):90-97. PubMed ID: 27872478
[TBL] [Abstract][Full Text] [Related]
20. Increased preoperative levels of plasma fibrinogen and D dimer in patients with renal cell carcinoma is associated with poor survival and adverse tumor characteristics.
Erdem S; Amasyali AS; Aytac O; Onem K; Issever H; Sanli O
Urol Oncol; 2014 Oct; 32(7):1031-40. PubMed ID: 25027687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]